The mechanisms underlying taste perception changes during GLP-1 therapy are likely multifactorial and indirect rather than representing true gustatory dysfunction
Semaglutide is a groundbreaking pharmaceutical agent, belonging to a class of drugs known as GLP-1 receptor agonists
Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice
Do not purchase compounded semaglutide from unverified online sellers and those who market the product as a miracle drug for weight loss and make exaggerated claims
Pettegrew JW, Levine J, McClure RJ: Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression
Tirzepatide, a dual GLP-1 and GIP receptor agonist, reduces appetite and improves metabolic functionbut some patients wonder about combining it with B12 supplementation